| 产品描述: | TCS 1102 is a potent, dual orexin receptor antagonist, with Ki values of 0.2 nM and 3 nM for OX2 and OX1 receptors, respectively. TCS 1102 demonstrates excellent brain peneration and moderate bioavailability in rats |
| 靶点: |
OX1 Receptor:3 nM (Ki);OX2 Receptor:0.2 nM (Ki);OXReceptor |
| 体内研究: |
TCS 1102 (compound 18) (15, 50, 100 mg/kg; i.p; single dose) induces locomotion inhibition in rat in a dose dependent manner. TCS-1102 (10 and 20 mg/kg; i.p.; single dose) decreases fear and anxiety in rats after exposure to footshock. Furthermore, TCS-1102 (10 mg/kg; i.p.; single dose) also shows anxiolytic effects for high responders (HR) rat when tested in the elevated T-maze. PK of TCS 1102 in Rat (100 mg/kg; i.p.; measured at 30 min) Animal Model: Male Sprague–Dawley rats (130-160 g) Dosage: 10 and 20 mg/kg Administration: Intraperitoneal injection; 30 min before received the footshocks Result: Decreased fear and anxiety in rats 14 days after exposure to footshock. |
| 参考文献: |
1. Bergman JM, et al. Proline bis-amides as potent dual orexin receptor antagonists. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1425-30. 2. Turku A, et al. Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity. PLoS One. 2017 Jun 2;12(6):e0178526. 3. Chen X, et al. Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks. Brain Struct Funct. 2013 Aug 18. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.125 ml |
10.625 ml |
21.25 ml |
| 5 mM |
0.425 ml |
2.125 ml |
4.25 ml |
| 10 mM |
0.213 ml |
1.063 ml |
2.125 ml |
| 50 mM |
0.043 ml |
0.213 ml |
0.425 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |